April 27, 2011
RECALL: American Regent Recalls Ammonium Molybdate InjectionAmerican Regent announced a voluntary nationwide recall of one lot of ammonium molybdate injection because of the presence of particulate matter. Potential adverse events after intravenous administration of solutions containing particulates may include disruption of blood flow within small blood vessels in the lungs, localized inflammation (eg, swelling and accumulation of inflammatory cells), and granuloma formation.
This recall is for Lot #9409 ammonium molybdate injection (molybdenum 250mcg/10mL) 10mL single-dose vials, manufactured by Luitpold Pharmaceuticals and distributed by American Regent.
Ammonium molybdate injection is indicated for use as a supplement to total parenteral nutrition (TPN) solutions. Administration of molybdenum in TPN solutions helps to prevent depletion of endogenous stores and subsequent deficiency symptoms.
For more information call (877) 788-3232 or visit www.americanregent.com.